KC
Congress trade
Rep. Katherine Clark (D-MA) bought $1K-$15K of Merck & Company, Inc. (MRK) stock
Katherine Clark, U.S. Representative (D-MA), disclosed a purchase of Merck & Company, Inc. (MRK) stock worth $1K-$15K in a STOCK Act filing on Aug 15, 2021.
The trade happened on Jul 27, 2021, 19 days before it was made public.
MRK has moved +85.4% since the trade date, from $77.85 to $144.30 (Oct 2, 2026 close).
- Traded
- Jul 27, 2021
- Disclosed
- Aug 15, 2021
- Filing delay
- 19 days
- Price since
- +85.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (39)
- SellABB$1K-$15KAug 15, 2021
- SellABB$1K-$15KAug 15, 2021
- BuyAY$1K-$15KAug 15, 2021
- BuyAY$1K-$15KAug 15, 2021
- BuyBBY$1K-$15KAug 15, 2021
- BuyBBY$1K-$15KAug 15, 2021
- SellBLK$1K-$15KAug 15, 2021
- SellBLK$1K-$15KAug 15, 2021
- BuyCSCO$1K-$15KAug 15, 2021
- BuyCSCO$1K-$15KAug 15, 2021
- SellEW$1K-$15KAug 15, 2021
- BuyFSLR$1K-$15KAug 15, 2021
- BuyFSLR$1K-$15KAug 15, 2021
- SellGOOG$1K-$15KAug 15, 2021
- SellGSK$1K-$15KAug 15, 2021
- SellGSK$1K-$15KAug 15, 2021
- BuyHD$1K-$15KAug 15, 2021
- BuyHD$1K-$15KAug 15, 2021
- BuyHON$1K-$15KAug 15, 2021
- BuyHON$1K-$15KAug 15, 2021
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.